comparemela.com

Latest Breaking News On - Beta hexoseaminidase - Page 1 : comparemela.com

Taysha Gene Therapies : Reports Second Quarter 2021 Financial Results and Provides Corporate Update

Positive pre-IND/CTA feedback obtained from several key regulatory agencies for TSHA-102 in Rett syndrome, TSHA-101 in GM2 gangliosidosis and TSHA-118 in CLN1 disease, paving the way for multiple. | August 17, 2021

Dallas
Texas
United-states
Omary-newman
Beta-hexoseaminidase
Silicon-valley-bank
Rare-disease-company-coalition
Queen-university
Us-national-institutes-of-health
Nasdaq
Exchange-commission
Development-rd-expenses

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.